Pacific Biosciences of California (PACB) News Today $1.72 0.00 (0.00%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Pacific Biosciences of California, Inc. (PACB): Among the Best Genomics Stocks to Buy Right NowNovember 20 at 11:42 AM | msn.comFY2024 EPS Estimates for PACB Reduced by Cantor FitzgeraldNovember 19 at 1:53 AM | americanbankingnews.comDeciphering Disruption: Inside Cathie Wood's Latest Plays (PACB)Cathie Wood's recent stock market activity offers a glimpse into her evolving investment strategy and the potential of disruptive technologies.November 18 at 3:14 PM | marketbeat.comSumitomo Mitsui Trust Group Inc. Cuts Stock Holdings in Pacific Biosciences of California, Inc. (NASDAQ:PACB)Sumitomo Mitsui Trust Group Inc. lessened its holdings in Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 6.1% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 11,865,766 shares of the biotechnolNovember 18 at 4:02 AM | marketbeat.comFY2024 EPS Estimates for PACB Lowered by Cantor FitzgeraldPacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) - Equities research analysts at Cantor Fitzgerald cut their FY2024 EPS estimates for Pacific Biosciences of California in a report released on Wednesday, November 13th. Cantor Fitzgerald analyst R. Osborn now anticipates that theNovember 18 at 1:49 AM | marketbeat.comPacific Biosciences of California (NASDAQ:PACB) Price Target Cut to $6.00 by Analysts at ScotiabankNovember 15, 2024 | americanbankingnews.comPacific Biosciences of California (NASDAQ:PACB) Stock Rating Upgraded by UBS GroupUBS Group upgraded Pacific Biosciences of California to a "hold" rating in a report on Sunday.November 14, 2024 | marketbeat.comPacific Biosciences' Cost Cuts Won't Offset Rising CompetitionNovember 12, 2024 | seekingalpha.comPacific Biosciences of California Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues LagNovember 12, 2024 | finance.yahoo.comCathie Wood Goes Bargain Hunting: 3 Stocks She Just BoughtNovember 12, 2024 | fool.comPacific Biosciences of California (NASDAQ:PACB) Stock Price Up 5.3% After Analyst UpgradePacific Biosciences of California (NASDAQ:PACB) Trading Up 5.3% on Analyst UpgradeNovember 12, 2024 | marketbeat.comUBS Downgrades Pacific Biosciences of California (PACB)November 12, 2024 | msn.comScotiabank Keeps Their Buy Rating on Pacific Biosciences (PACB)November 12, 2024 | markets.businessinsider.comScotiabank Lowers Pacific Biosciences of California (NASDAQ:PACB) Price Target to $6.00Scotiabank lowered their target price on Pacific Biosciences of California from $7.00 to $6.00 and set a "sector outperform" rating on the stock in a research report on Monday.November 11, 2024 | marketbeat.comPacific Biosciences of California Target of Unusually High Options Trading (NASDAQ:PACB)Pacific Biosciences of California, Inc. (NASDAQ:PACB - Get Free Report) saw unusually large options trading on Monday. Investors purchased 10,101 call options on the stock. This represents an increase of 271% compared to the average daily volume of 2,719 call options.November 11, 2024 | marketbeat.comPacific Biosciences of California (NASDAQ:PACB) Rating Lowered to "Neutral" at UBS GroupUBS Group cut Pacific Biosciences of California from a "buy" rating to a "neutral" rating in a research note on Monday.November 11, 2024 | marketbeat.comPacific Biosciences of California (NASDAQ:PACB) Given New $2.50 Price Target at Piper SandlerPiper Sandler raised their target price on Pacific Biosciences of California from $2.00 to $2.50 and gave the company a "neutral" rating in a research note on Monday.November 11, 2024 | marketbeat.comPacific Biosciences of California, Inc. (NASDAQ:PACB) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | msn.comPacific Biosciences of California, Inc. (NASDAQ:PACB) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesShares of Pacific Biosciences of California, Inc. (NASDAQ:PACB - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the fifteen ratings firms that are currently covering the firm, Marketbeat.com reports. Seven research analysts have rated the stock with a hold recommendatNovember 9, 2024 | marketbeat.comBarclays Reaffirms Their Hold Rating on Pacific Biosciences (PACB)November 8, 2024 | markets.businessinsider.comPacBio to Present at Upcoming Investor ConferencesNovember 8, 2024 | globenewswire.comPacific Biosciences of California (NASDAQ:PACB) Shares Gap Down - What's Next?Pacific Biosciences of California (NASDAQ:PACB) Shares Gap Down - Should You Sell?November 8, 2024 | marketbeat.comPacific Biosciences of California Inc (PACB) Q3 2024 Earnings Call Highlights: Navigating ...November 8, 2024 | finance.yahoo.comPacific Biosciences of California, Inc. (PACB) Q3 2024 Earnings Call TranscriptNovember 7, 2024 | seekingalpha.comTD Cowen Keeps Their Buy Rating on Pacific Biosciences (PACB)November 7, 2024 | markets.businessinsider.comPacific Biosciences of California, Inc. 2024 Q3 - Results - Earnings Call PresentationNovember 7, 2024 | seekingalpha.comPacBio Announces a Private Convertible Exchange Transaction of $459 Million Principal Amount of 1.50% Convertible Senior Notes due 2028November 7, 2024 | globenewswire.comPacific Biosciences of California Inc (PACB) Q3 2024 Earnings Report Preview: What To ExpectNovember 7, 2024 | finance.yahoo.comPacBio Unveils the Vega System, a New Sequencing Platform Bringing HiFi to the BenchtopNovember 6, 2024 | globenewswire.comAssenagon Asset Management S.A. Trims Stock Position in Pacific Biosciences of California, Inc. (NASDAQ:PACB)Assenagon Asset Management S.A. cut its position in Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 78.2% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 281,887 shares of theNovember 4, 2024 | marketbeat.comPacific Biosciences of California (PACB) to Release Quarterly Earnings on ThursdayPacific Biosciences of California (NASDAQ:PACB) will be releasing earnings after the market closes on Thursday, November 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=634755)October 31, 2024 | marketbeat.comPacific Biosciences (PACB): Promising Gene Editing Stock With Innovating TechnologyOctober 30, 2024 | msn.comVolta Labs joins PacBio Compatible program to help PacBio customers scale sequencing through automated library prepOctober 30, 2024 | prnewswire.comPacBio announces SPRQ chemistry for Revio sequencing systemsOctober 30, 2024 | markets.businessinsider.comPacific Biosciences of California, Inc. (NASDAQ:PACB) is a favorite amongst institutional investors who own 86%October 30, 2024 | finance.yahoo.comPacific Biosciences of California (NASDAQ:PACB) Stock Price Up 5.7% - Still a Buy?Pacific Biosciences of California (NASDAQ:PACB) Stock Price Up 5.7% - Here's WhyOctober 29, 2024 | marketbeat.comPacBio Announces SPRQ Chemistry for Revio Sequencing Systems, a Major Advance Reducing the Cost of a HiFi Human Genome to less than $500October 29, 2024 | globenewswire.comPacBio Onso™ Short Read Sequencing Instrument Joins 10x Genomics Compatible Partner ProgramOctober 22, 2024 | globenewswire.comPacific Biosciences of California (NASDAQ:PACB) Shares Down 4.8% - Should You Sell?Pacific Biosciences of California (NASDAQ:PACB) Shares Down 4.8% - Here's WhyOctober 16, 2024 | marketbeat.comPacific Biosciences of California (NASDAQ:PACB) Shares Gap Down - Here's What HappenedPacific Biosciences of California (NASDAQ:PACB) Shares Gap Down - Here's What HappenedOctober 14, 2024 | marketbeat.comDimensional Fund Advisors LP Sells 2,121,331 Shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB)Dimensional Fund Advisors LP lowered its position in Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 61.8% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,313,137 shares of the biotechnology company'October 12, 2024 | marketbeat.comPacific Biosciences of California (NASDAQ:PACB) Stock Price Up 18.4% - Here's WhyPacific Biosciences of California (NASDAQ:PACB) Stock Price Up 18.4% - Here's WhyOctober 11, 2024 | marketbeat.comPacBio Enters Cancer Genomics Research Collaboration in Singapore with Advanced Onso SequencingOctober 11, 2024 | globenewswire.comPacBio to Report Third Quarter 2024 Financial Results on November 7, 2024October 10, 2024 | globenewswire.comSquarepoint Ops LLC Invests $719,000 in Pacific Biosciences of California, Inc. (NASDAQ:PACB)Squarepoint Ops LLC purchased a new position in Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 524,608 shares of the biotechnology comOctober 8, 2024 | marketbeat.comMarshall Wace LLP Raises Stake in Pacific Biosciences of California, Inc. (NASDAQ:PACB)Marshall Wace LLP increased its stake in Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 226.6% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,611,300 shares of the biotechnologOctober 5, 2024 | marketbeat.comPacBio, A*STAR, and Macrogen Unveil State-of-the-Art Lab to Accelerate Genomics Innovation in SingaporeOctober 1, 2024 | globenewswire.comPacBio Grants Equity Incentive Award to New EmployeeSeptember 27, 2024 | globenewswire.comPacific Biosciences of California, Inc. Is Being Investigated For Violating Securities Laws And The Schall Law Firm Urges Shareholder ParticipationSeptember 25, 2024 | stockhouse.comPacific Biosciences of California, Inc. (NASDAQ:PACB) Shares Sold by Oracle Investment Management Inc.Oracle Investment Management Inc. lessened its position in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 73.7% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 423,138 shares of the biotechnologySeptember 24, 2024 | marketbeat.com Get Pacific Biosciences of California News Delivered to You Automatically Sign up to receive the latest news and ratings for PACB and its competitors with MarketBeat's FREE daily newsletter. Email Address This company will win the AI race (Ad)Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse. You must read this new presentation from Porter Stansberry. PACB Media Mentions By Week PACB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PACB News Sentiment▼0.050.45▲Average Medical News Sentiment PACB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PACB Articles This Week▼114▲PACB Articles Average Week Get Pacific Biosciences of California News Delivered to You Automatically Sign up to receive the latest news and ratings for PACB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies HBIO News Today TMO News Today A News Today MTD News Today ILMN News Today WAT News Today TECH News Today CRL News Today BIO News Today BRKR News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PACB) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pacific Biosciences of California, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pacific Biosciences of California With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
